Business buzzwords

Most specialty drug companies obtain product rights only for one or two national markets and so cannot fund clinical development and sales expansion by sub-licensing or partnering; they must sell equity to finance 100% of development & marketing costs, resulting in highly ..... founders and lower returns for all their investors.